[ad_1]
The final clinical trial of the corona vaccine conducted by AstraZeneca and the University of Oxford has been postponed.
According to the BBC, one of the volunteers who took part in the trial in the UK fell ill after receiving the vaccine and his final clinical trial has been postponed.
AstraZeneca referred to these breaks as part of “routine” work. However, the details of the adverse reaction in the volunteer’s body were not known.
The corona vaccine, developed by the University of Oxford, is being closely monitored around the world. Of all the efforts being made around the world to develop the Covid-19 vaccine, the AstraZeneca-Oxford University vaccine is considered the most promising.
With the successful completion of the first and second phase trials, this vaccine was expected to be the first to hit the market.
Phase III trials recently began with about 30,000 participants in the United States, the United Kingdom, Brazil, and South Africa. In the third stage, thousands of people are examined. Many times it can last for several years.
BBC Health Editor Fergus Walsh said all international testing of the vaccine would be suspended until an independent evaluator could verify its safety. It will then be decided whether to resume exam activities.
A spokesperson for the University of Oxford said: However, it should be carefully reviewed by an independent examiner.
However, test activities are expected to start again in a few days.
The news was first published by state health news Stat News. According to Stat News, the body of one of the participants in the UK had a reaction, the cause of which was not immediately known.
However, he is expected to recover soon.
